title: [Incretin therapy and diabetic retinopathy].
abstract: Therapy based on incretins presents a new group of medicinal substances designated for an intervention in patients with type 2 diabetes. It includes a therapy that is efficient, safe and effective. Its advantage is a low risk of hypoglycaemia and a positive effect on body weight. The analyses that have been published so far consistently indicate a positive impact on cardiovascular risk factors. The first studies conducted on animal models prove a favourable influence ofincretin therapy on the pathophysiology of diabetic retinopathy.
authors.affiliation: Interní klinika 2. lékarské fakulty UKa FN Motol Praha. Interna@fnmotol.cz
authors.forename: M
authors.initials: M
authors.lastname: Kvapil
mesh_terms: D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D003930:Diabetic Retinopathy / Q000188:drug therapy*; D006801:Humans; D054795:Incretins / Q000627:therapeutic use*
chemical_list: D054795:Incretins